Irene A. Eiseman
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 6
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Peter F. Lenehan (9 shared papers)Lee F. Allen (2 shared papers)Stephen C. Olson (7 shared papers)Kenneth J. Tack (4 shared papers)Dan J. Fry (1 shared paper)W ELLIOTT (1 shared paper)Ghodrat A. Siami (1 shared paper)Nicholas V. Christou (1 shared paper)
- Journals
- Clinical Cancer Research (5 papers)Drugs (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Seminars in Oncology (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Irene A. Eiseman
17 papers receiving 559 citations
Peers
Comparison fields: 5 of 60
- Oncology 357
- Pulmonary and Respiratory Medicine 228
- Radiology, Nuclear Medicine and Imaging 105
- Rehabilitation 23
- Molecular Medicine 17
Countries citing papers authored by Irene A. Eiseman
This map shows the geographic impact of Irene A. Eiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene A. Eiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene A. Eiseman more than expected).
Fields of papers citing papers by Irene A. Eiseman
This network shows the impact of papers produced by Irene A. Eiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene A. Eiseman. The network helps show where Irene A. Eiseman may publish in the future.
Co-authors
The 25 scholars most cited alongside Irene A. Eiseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 102 | |
| 2 | 2002 | 88 | |
| 3 | 2005 | 78 | |
| 4 | 2004 | 74 | |
| 5 | 2001 | 67 | |
| 6 | 2002 | 59 | |
| 7 | 2006 | 27 | |
| 8 | 2006 | 26 | |
| 9 | 2007 | 24 | |
| 10 | 1995 | 18 | |
| 11 | 2006 | 15 | |
| 12 | 2006 | 11 | |
| 13 | 2001 | 9 | |
| 14 | 2004 | 9 | |
| 15 | 1983 | 5 | |
| 16 | 1986 | 1 | |
| 17 | 1999 | 1 |
About Irene A. Eiseman
Irene A. Eiseman is a scholar working on Oncology, Infectious Diseases, Pharmacology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 614 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Lung Cancer Treatments and Mutations (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Infectious Diseases and Tuberculosis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Oncology (357 citations), Pulmonary and Respiratory Medicine (228 citations), Radiology, Nuclear Medicine and Imaging (105 citations), Rehabilitation (23 citations) and Molecular Medicine (17 citations). Irene A. Eiseman has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Peter F. Lenehan, Lee F. Allen, Stephen C. Olson, Kenneth J. Tack, Dan J. Fry, W ELLIOTT, Ghodrat A. Siami, Nicholas V. Christou, Ralph Zinner and David W. Fry. Their work appears in journals such as Clinical Cancer Research, Drugs, Antimicrobial Agents and Chemotherapy, Seminars in Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.